Torrent Pharmaceuticals has raised funds through issuance of Commercial Paper (CPs) for an amount of approximately Rs 200 crore on May 03, 2019. The Tenure of the instrument is 136 days, having a maturity date of September 16, 2019. Credit rating agency, ICRA has granted rating of ‘A1 +’ for issuance of Commercial papers by the company.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
The post Torrent Pharmaceuticals raises Rs 200 crore via CPs appeared first on Udaipur News | Udaipur Latest News | udaipur local news.
